Neocoronaviral oral medications have side effects that do not occur in all users.
According to the ninth edition of the new crown pneumonia diagnosis and treatment guidelines, China is currently the main use of the new crown oral drugs to ritonavir and ambavizumab, such drugs may appear rash, eczema, nausea and vomiting, diarrhea, liver function damage and other side effects, related tests such as triglycerides and other indicators may also appear to be elevated.
Although there are side effects associated with New Crown oral medications, it does not mean that all people taking the medication will experience similar manifestations, and may experience varying degrees of adverse reactions, or no adverse reactions, depending on individual constitution and other factors. If the new crown pneumonia diagnosed cases, to the new crown pneumonia treatment, follow-up adverse reactions to take symptomatic treatment can be, prescription drugs to follow the doctor’s instructions.
[Tip] This article refers to “new coronary pneumonia, new coronary virus pneumonia”, etc., has been December 26, 2022, the National Health Commission issued a notice to change the name to “new coronary virus infection”.